Effects of Pulmonary Hypertension in Patients with Chronic Kidney Disease

7th International Congress of Cardionephrology KARNEF (2025) [pp. 119-121]

AUTHOR(S) / AUTOR(I): Davide Viggiano

Download Full Pdf   

DOI: 10.46793/KARNEF25.124V

ABSTRACT / SAŽETAK:

Pulmonary hypertension (PH) is a significant comorbidity in chronic kidney disease (CKD), with complex mechanisms linking the renal, cardiovascular, and pulmonary systems. Signs of pulmonary insufficiency and right heart failure should prompt transthoracic echocardiography with an estimate of pulmonary artery systolic pressure (PASP) from tricuspid regurgitation velocity.

KEYWORDS / KLJUČNE REČI:

Pulmonary hypertension, Chronic kidney disease, Dialysis

REFERENCES / LITERATURA:

  • Bolignano, D et al. Pulmonary Hypertension in CKD. American Journal of Kidney Diseases, Volume 61, Issue 4, 612 – 622 (2012)
  • Zeder, K., Siew, E.D., Kovacs, G. et al. Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes. Nat Rev Nephrol 20, 742–754 (2024)